Significance of Five-Membered Heterocycles in Human Histone Deacetylase Inhibitors.
active pharmaceutical ingredient
active substance optimization
drug design
drug development
histone deacetylase inhibitors
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
27 Jul 2023
27 Jul 2023
Historique:
received:
29
05
2023
revised:
15
07
2023
accepted:
15
07
2023
medline:
14
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
Five-membered heteroaromatic rings, in particular, have gained prominence in medicinal chemistry as they offer enhanced metabolic stability, solubility and bioavailability, crucial factors in developing effective drugs. The unique physicochemical properties and biological effects of five-membered heterocycles have positioned them as key structural motifs in numerous clinically effective drugs. Hence, the exploration of five-ring heterocycles remains an important research area in medicinal chemistry, with the aim of discovering new therapeutic agents for various diseases. This review addresses the incorporation of heteroatoms such as nitrogen, oxygen and sulfur into the aromatic ring of these heterocyclic compounds, enhancing their polarity and facilitating both aromatic stacking interactions and the formation of hydrogen bonds. Histone deacetylases are present in numerous multiprotein complexes within the epigenetic machinery and play a central role in various cellular processes. They have emerged as important targets for cancer, neurodegenerative diseases and other therapeutic indications. In histone deacetylase inhibitors (HDACi's), five-ring heterocycles perform various functions as a zinc-binding group, a linker or head group, contributing to binding activity and selective recognition. This review focuses on providing an up-to-date overview of the different five-membered heterocycles utilized in HDACi motifs, highlighting their biological properties. It summarizes relevant publications from the past decade, offering insights into the recent advancements in this field of research.
Identifiants
pubmed: 37570656
pii: molecules28155686
doi: 10.3390/molecules28155686
pmc: PMC10419652
pii:
doi:
Substances chimiques
Histone Deacetylase Inhibitors
0
Heterocyclic Compounds
0
Histone Deacetylases
EC 3.5.1.98
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM129325
Pays : United States
Références
R Soc Open Sci. 2019 Jun 5;6(6):190338
pubmed: 31312496
J Biol Chem. 2008 Sep 26;283(39):26694-704
pubmed: 18614528
Sci Rep. 2021 May 21;11(1):10668
pubmed: 34021207
Eur J Med Chem. 2016 Feb 15;109:350-9
pubmed: 26814680
Pharmaceuticals (Basel). 2021 Oct 11;14(10):
pubmed: 34681256
Sci Rep. 2021 Jul 29;11(1):15423
pubmed: 34326423
Int J Mol Sci. 2019 Feb 21;20(4):
pubmed: 30795625
Molecules. 2018 Dec 18;23(12):
pubmed: 30567416
ChemMedChem. 2014 Mar;9(3):657-64
pubmed: 24403121
Drugs Today (Barc). 2009 Nov;45(11):787-95
pubmed: 20126671
Bioorg Chem. 2021 May;110:104801
pubmed: 33756235
Bioorg Med Chem. 2014 Nov 1;22(21):5766-75
pubmed: 25311567
Am Health Drug Benefits. 2016 Mar;9(Spec Feature):84-7
pubmed: 27668050
J Med Chem. 2013 Dec 27;56(24):9934-54
pubmed: 24261862
Eur J Med Chem. 2018 Feb 25;146:79-92
pubmed: 29396364
Apoptosis. 2017 Nov;22(11):1394-1403
pubmed: 28840369
J Med Chem. 2018 Nov 21;61(22):10000-10016
pubmed: 30347148
Bioorg Chem. 2020 Aug;101:103988
pubmed: 32534346
Chem Commun (Camb). 2022 Oct 4;58(79):11087-11090
pubmed: 36098075
Bioorg Chem. 2017 Apr;71:160-169
pubmed: 28196602
Future Med Chem. 2020 Apr;12(8):655-672
pubmed: 32202140
J Med Chem. 2023 Apr 13;66(7):4802-4826
pubmed: 36934335
Chem Pharm Bull (Tokyo). 1984 Nov;32(11):4460-5
pubmed: 6532548
Bioorg Med Chem. 2016 Nov 1;24(21):5611-5617
pubmed: 27665180
J Biol Chem. 2023 Jan;299(1):102800
pubmed: 36528061
Bioorg Chem. 2021 Nov;116:105350
pubmed: 34547645
Eur J Med Chem. 2019 Sep 15;178:116-130
pubmed: 31177073
J Med Chem. 2020 Nov 12;63(21):12290-12358
pubmed: 32686940
Mar Drugs. 2019 Jun 03;17(6):
pubmed: 31163697
Pharmacol Ther. 2009 Sep;123(3):344-52
pubmed: 19464317
Eur J Med Chem. 2022 Jan 15;228:114011
pubmed: 34875522
J Med Chem. 2016 Feb 25;59(4):1545-55
pubmed: 26653328
J Med Chem. 2012 Mar 8;55(5):1817-30
pubmed: 22185670
Bioorg Med Chem. 2015 Jul 1;23(13):3457-71
pubmed: 25953722
Pest Manag Sci. 2020 Oct;76(10):3357-3368
pubmed: 32369266
J Am Chem Soc. 2011 Aug 17;133(32):12474-7
pubmed: 21790156
J Chem Inf Model. 2015 Apr 27;55(4):861-71
pubmed: 25757142
Bioorg Med Chem Lett. 2020 Sep 1;30(17):127367
pubmed: 32738976
Chem Biodivers. 2021 Dec;18(12):e2100651
pubmed: 34626068
PLoS Biol. 2013 Nov;11(11):e1001717
pubmed: 24302884
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Bioorg Chem. 2020 Jul;100:103934
pubmed: 32446120
ACS Chem Biol. 2017 Jun 16;12(6):1644-1655
pubmed: 28459537
J Med Chem. 2016 Dec 8;59(23):10642-10660
pubmed: 27809521
ACS Med Chem Lett. 2013 Sep 04;4(10):994-9
pubmed: 24900596
ACS Med Chem Lett. 2020 Jun 22;11(7):1476-1483
pubmed: 32676157
Bioorg Med Chem Lett. 2019 Jan 1;29(1):15-21
pubmed: 30455152
ACS Med Chem Lett. 2016 Sep 01;7(10):929-932
pubmed: 27774131
Curr Opin Struct Biol. 2011 Dec;21(6):735-43
pubmed: 21872466
J Med Chem. 2017 Sep 14;60(17):7333-7349
pubmed: 28817930
Blood Cancer J. 2016 Dec 2;6(12):e503
pubmed: 27911437
Clin Cancer Res. 2015 Jun 15;21(12):2666-70
pubmed: 25802282
ACS Med Chem Lett. 2021 Feb 11;12(3):380-388
pubmed: 33738065
Bioorg Chem. 2020 Jan;95:103522
pubmed: 31901516
J Med Chem. 2020 Jan 23;63(2):804-815
pubmed: 31855601
Angew Chem Int Ed Engl. 2010 Sep 10;49(38):6817-20
pubmed: 20715030
J Med Chem. 2020 Nov 12;63(21):12460-12484
pubmed: 32608981
Bioorg Med Chem. 2021 Jul 15;42:116251
pubmed: 34116381
Mol Cell Biol. 2008 Mar;28(5):1688-701
pubmed: 18180281
Med Chem. 2018;14(8):831-850
pubmed: 29807520
Bioorg Med Chem Lett. 2020 Jul 1;30(13):127197
pubmed: 32331932
RSC Med Chem. 2021 Jul 27;12(9):1540-1554
pubmed: 34671737
Nat Chem Biol. 2013 May;9(5):319-25
pubmed: 23524983
J Med Chem. 2021 May 27;64(10):6949-6971
pubmed: 34006099
J Biol Chem. 2013 Sep 13;288(37):26926-43
pubmed: 23897821
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19183-7
pubmed: 19047631
Eur J Med Chem. 2015;96:1-13
pubmed: 25874326
Bioorg Med Chem Lett. 2016 Jan 15;26(2):375-379
pubmed: 26706171
ACS Med Chem Lett. 2018 Nov 27;10(4):481-486
pubmed: 30996783
Bioorg Med Chem Lett. 2008 Dec 1;18(23):6078-82
pubmed: 18952417
Int J Mol Sci. 2022 Nov 02;23(21):
pubmed: 36362189
Chem Pharm Bull (Tokyo). 2014;62(12):1185-91
pubmed: 25450627
Intractable Rare Dis Res. 2016 Aug;5(3):185-91
pubmed: 27672541
Eur J Med Chem. 2014 Oct 30;86:639-52
pubmed: 25218912
Cell Mol Life Sci. 2008 Jul;65(13):2039-55
pubmed: 18360740
Eur J Med Chem. 2016 Apr 13;112:81-90
pubmed: 26890114
Bioorg Med Chem. 2015 Aug 1;23(15):4481-4488
pubmed: 26122774
Int J Mol Sci. 2023 Mar 01;24(5):
pubmed: 36902164
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Drugs Today (Barc). 2007 Sep;43(9):585-99
pubmed: 17940636
PLoS One. 2013 Jul 16;8(7):e68669
pubmed: 23874714
Bioorg Med Chem. 2019 Aug 1;27(15):3408-3420
pubmed: 31235266